Home » EMEA 2007 Agenda Reflects Impact of Pediatric Medicines Rule
EMEA 2007 Agenda Reflects Impact of Pediatric Medicines Rule
February 15, 2007
Implementing the new pediatric medicines legislation will be a major priority in the coming year and will have an impact on existing core activities, such as scientific advice, quality and risk management and postmarketing surveillance, the European Medicines Agency (EMEA) says in its 2007 Work Program.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor